Literature DB >> 16729148

Metal complexes of maltol and close analogues in medicinal inorganic chemistry.

Katherine H Thompson1, Cheri A Barta, Chris Orvig.   

Abstract

The family of hydroxypyrones and close congeners, the hydroxypyridinones, is a particularly versatile class of ligands. The most widely investigated for medicinal applications are the 3-hydroxy-4-pyrones and the 1,2- 3,2- and 3,4-hydroxypyridinones. Key features of these ligands are: a six-membered ring, with a ring N or O atom either ortho or para to a ketone group, and two ortho exocyclic oxygen atoms. Readily functionalizable, the hydroxypyrones and hydroxypyridinones allow one to achieve a range of di- and trivalent metallocomplex stabilities and can include tissue or molecular targeting features by design. Research over the past several decades has greatly expanded the array of ligands that are the subject of this critical review. Ligand applications as diverse as iron removal or supplementation, contrast agents in imaging applications, and mobilization of undesirable excess metal ions will be surveyed herein.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16729148     DOI: 10.1039/b416256k

Source DB:  PubMed          Journal:  Chem Soc Rev        ISSN: 0306-0012            Impact factor:   54.564


  17 in total

Review 1.  Gallium-containing anticancer compounds.

Authors:  Christopher R Chitambar
Journal:  Future Med Chem       Date:  2012-06       Impact factor: 3.808

2.  New Synthetic Approach for the Incorporation of 3,2-Hydroxypyridinone (HOPO) Ligands: Synthesis of Structurally Diverse Poly HOPO Chelators.

Authors:  Jayanthi Arumugam; Hayley A Brown; Hollie K Jacobs; Aravamudan S Gopalan
Journal:  Synthesis (Stuttg)       Date:  2011-01-01       Impact factor: 3.157

3.  Chemical and functional properties of metal chelators that mobilize copper to elicit fungal killing of Cryptococcus neoformans.

Authors:  Marian E Helsel; Elizabeth J White; Sayyeda Zeenat A Razvi; Bruno Alies; Katherine J Franz
Journal:  Metallomics       Date:  2017-01-25       Impact factor: 4.526

4.  New methodology for the preparation of 3-hydroxy-2-pyridinone (3,2-HOPO) chelators and extractants. Part 2. Reactions of alcohols, phenols, and thiols with an electrophilic 3,2-HOPO reagent().

Authors:  Sumathi Chittamuru; Timothy N Lambert; Gloria Martinez; Hollie K Jacobs; Aravamudan S Gopalan
Journal:  Tetrahedron Lett       Date:  2007-01-20       Impact factor: 2.415

5.  Screening chelating inhibitors of HIF-prolyl hydroxylase domain 2 (PHD2) and factor inhibiting HIF (FIH).

Authors:  Shannon C Flagg; Cristina B Martin; Cornelius Y Taabazuing; Breanne E Holmes; Michael J Knapp
Journal:  J Inorg Biochem       Date:  2012-03-17       Impact factor: 4.155

6.  Regulation of mGluR1 on the Expression of PKC and NMDAR in Aluminum-Exposed PC12 Cells.

Authors:  Chanting He; Xiaoyan Zhao; Huan Li; Fei Wang; Jingsi Zhang; Yanni Wang; Yingchao Han; Chunman Yuan; Qiao Niu
Journal:  Neurotox Res       Date:  2021-01-19       Impact factor: 3.911

7.  3,2-Hydroxypyridinone (3,2-HOPO) vinyl sulfonamide and acrylamide linkers: Aza-Michael addition reactions and the preparation of poly-HOPO chelators.

Authors:  Gloria Martinez; Jayanthi Arumugam; Hollie K Jacobs; Aravamudan S Gopalan
Journal:  Tetrahedron Lett       Date:  2013-02-13       Impact factor: 2.415

8.  Synthesis of hydroxypyrone- and hydroxythiopyrone-based matrix metalloproteinase inhibitors: developing a structure-activity relationship.

Authors:  Yi-Long Yan; Melissa T Miller; Yuchen Cao; Seth M Cohen
Journal:  Bioorg Med Chem Lett       Date:  2009-02-14       Impact factor: 2.823

9.  Kinetic characterization of the inhibition of protein tyrosine phosphatase-1B by Vanadyl (VO2+) chelates.

Authors:  Jason Hon; Michelle S Hwang; Meara A Charnetzki; Issra J Rashed; Patrick B Brady; Sarah Quillin; Marvin W Makinen
Journal:  J Biol Inorg Chem       Date:  2017-10-25       Impact factor: 3.358

10.  Efficient synthesis of 5-amido-3-hydroxy-4-pyrones as inhibitors of matrix metalloproteinases.

Authors:  Yi-Long Yan; Seth M Cohen
Journal:  Org Lett       Date:  2007-05-24       Impact factor: 6.005

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.